MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...

Russia's announcement of a personalised mRNA cancer vaccine has generated excitement, but experts urge caution. While mRNA ...

When Xiao Wang applied to faculty jobs, many of the institutions where she interviewed thought her research proposal - to ...

Biomedical engineers at Duke University have demonstrated a new synthetic approach that turbocharges bacteria into producing ...

Nearly 3 months after the FDA green-lit the TTR stabilizer, it joins tafamidis as the second therapy in Europe for the ...

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

Our closest relationships promise us great rewards and we enrich them by bringing a full representation of who we are.